MCM
JAZZ icon

Manchester Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Manchester Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.05K Hold
32
– – ﹤0.01% 870
2025
Q4 		$5.44K Buy
32
+8
+33% +$1.23K ﹤0.01% 874
2025
Q3 		$3.16K Hold
24
– – ﹤0.01% 1015
2025
Q2 		$2.55K Sell
24
-100
-81% -$10.9K ﹤0.01% 979
2025
Q1 		$15.4K Buy
124
+100
+417% +$13K ﹤0.01% 764
2024
Q4 		$2.96K Hold
24
– – ﹤0.01% 956
2024
Q3 		$2.67K Sell
24
-15
-38% -$1.64K ﹤0.01% 966
2024
Q2 		$4.16K Buy
39
+33
+550% +$3.63K ﹤0.01% 869
2024
Q1 		$723 Buy
+6
New +$735 ﹤0.01% 908

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Manchester Capital Management's JAZZ Position: Q1 2026 in Review

Manchester Capital Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 32 shares worth $6.05K. The position accounts for ﹤0.01% of the portfolio, ranked #870.

Manchester Capital Management first reported a position in JAZZ in Q1 2024 and has held it in 9 quarters since. The position peaked at $15.4K in Q1 2025. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Manchester Capital Management held 32 shares of Jazz Pharmaceuticals worth $6.05K as of Q1 2026.
  • Manchester Capital Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Manchester Capital Management's portfolio in Q1 2026, its #870 holding.
  • Manchester Capital Management first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Manchester Capital Management's Jazz Pharmaceuticals position peaked at $15.4K in Q1 2025.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.